Management Differences Between Unstable and Stable Angina
The management of unstable angina requires immediate hospitalization, intensive antiplatelet therapy, and early consideration for invasive strategy, while stable angina can be managed primarily with outpatient medical therapy and lifestyle modifications. 1
Definitions and Clinical Presentation
Unstable Angina
- Characterized by one of three presentations: rest pain (lasting up to 20 minutes), rapidly increasing crescendo angina (progressively worsening over 4 weeks or less), or new onset severe angina within 2 months of initial presentation 1
- Part of the acute coronary syndrome spectrum along with non-ST-elevation myocardial infarction (NSTEMI) 2
- Typically associated with plaque rupture and overlying thrombus formation 2
Stable Angina
- Predictable chest pain occurring with exertion or emotional stress 1
- Relieved by rest and/or nitroglycerin 1
- Symptoms remain consistent in pattern, frequency, and intensity over time 1
Acute Management Differences
Unstable Angina Management
- Immediate hospitalization with continuous ECG monitoring for ischemia and arrhythmia detection in patients with ongoing rest pain 1
- Aggressive antiplatelet therapy:
- Anticoagulation: Unfractionated heparin or low-molecular-weight heparin (enoxaparin preferred) 1
- Early risk stratification using clinical criteria, ECG changes, and cardiac biomarkers 1
- Early invasive strategy (coronary angiography within 24-48 hours) recommended for high and intermediate-risk patients 1
Stable Angina Management
- Outpatient management is typically appropriate 1
- Anti-anginal medications should be optimized sequentially:
- Antiplatelet therapy: Aspirin 75 mg daily 1
- Statin therapy for all patients 1
- Functional testing to confirm diagnosis and determine prognosis 1
- Consider coronary angiography only when symptoms are not satisfactorily controlled by medical therapy 1
Revascularization Approach
Unstable Angina
- Early invasive strategy (within 24-48 hours) recommended for high and intermediate-risk patients 1
- Immediate angiography for patients with refractory symptoms, hemodynamic instability, or persistent ECG changes despite medical therapy 1
- PCI with stenting is effective with improved outcomes when combined with dual antiplatelet therapy 1
- CABG preferred for diabetic patients with multivessel disease 1
Stable Angina
- Conservative approach with medical optimization first 1
- Elective coronary angiography only when symptoms are not satisfactorily controlled by medical therapy 1
- PCI is effective for symptom control but has not been shown to reduce mortality compared to medical therapy 1
- CABG may be considered for specific anatomical patterns (left main, proximal LAD, or three-vessel disease, especially with LV dysfunction) 1
Follow-up and Long-term Management
Unstable Angina
- Close follow-up: High-risk patients should return in 1-2 weeks, lower-risk patients in 2-6 weeks 1
- Aggressive secondary prevention including smoking cessation, diet, exercise, and optimal control of comorbidities 1
- Long-term dual antiplatelet therapy (typically 12 months) after ACS 3
Stable Angina
- Regular outpatient follow-up to assess symptom control 1
- Optimize medical therapy before adding additional agents 1
- Risk factor modification including lifestyle changes and management of comorbidities 1
- Consider functional testing to evaluate response to therapy 4
Common Pitfalls and Caveats
- Failure to recognize unstable angina as a medical emergency requiring hospitalization 1
- Delaying antiplatelet therapy in unstable angina patients 1
- Premature invasive management of low-risk patients with stable angina 1
- Inadequate risk stratification in patients with chest pain 1
- Overlooking the importance of secondary prevention measures in both conditions 1
- Not considering coronary angiography in stable angina patients with persistent symptoms despite optimal medical therapy 1
By understanding these key differences in management approaches, clinicians can provide appropriate care based on the presentation and risk stratification of patients with angina.